136 related articles for article (PubMed ID: 21789021)
21. Static magnetic field enhances the anticancer efficacy of capsaicin on HepG2 cells via capsaicin receptor TRPV1.
Chen WT; Lin GB; Lin SH; Lu CH; Hsieh CH; Ma BL; Chao CY
PLoS One; 2018; 13(1):e0191078. PubMed ID: 29338036
[TBL] [Abstract][Full Text] [Related]
22. In vitro investigations of new therapeutic agents on bladder tumor cell lines.
Kugler A; Haschemi R; Zöller G; Gross AJ; Kallerhoff M; Ringert RH
Urol Res; 1997; 25(4):247-50. PubMed ID: 9286032
[TBL] [Abstract][Full Text] [Related]
23. Lack of in vitro interactions using human liver microsomes between rabeprazole and anticancer drugs.
Tamaro I; Genazzani A; Canonico P; Grosa G
Eur J Drug Metab Pharmacokinet; 2009; 34(1):19-26. PubMed ID: 19462924
[TBL] [Abstract][Full Text] [Related]
24. Novel morphological features in the death of MCF-7 human breast cancer cells after exposure to anticancer drugs.
Kugawa F; Dalkhuren SO; Ueno A; Yamashita K
Pharmazie; 2012 Oct; 67(10):862-9. PubMed ID: 23136722
[TBL] [Abstract][Full Text] [Related]
25. Moderate intensity static magnetic fields affect mitotic spindles and increase the antitumor efficacy of 5-FU and Taxol.
Luo Y; Ji X; Liu J; Li Z; Wang W; Chen W; Wang J; Liu Q; Zhang X
Bioelectrochemistry; 2016 Jun; 109():31-40. PubMed ID: 26775206
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
Thigpen T; Vance R; Puneky L; Khansur T
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds.
Witte AB; Anestål K; Jerremalm E; Ehrsson H; Arnér ES
Free Radic Biol Med; 2005 Sep; 39(5):696-703. PubMed ID: 16085187
[TBL] [Abstract][Full Text] [Related]
28. Potentiation of the anti-proliferative effects of anti-cancer drugs by octreotide in vitro and in vivo.
Weckbecker G; Raulf F; Tolcsvai L; Bruns C
Digestion; 1996; 57 Suppl 1():22-8. PubMed ID: 8813462
[TBL] [Abstract][Full Text] [Related]
29. Correlation of chemosensitivity to anticancer drugs and telomere length, telomerase activity and telomerase RNA expression in human ovarian cancer cells.
Kiyozuka Y; Yamamoto D; Yang J; Uemura Y; Senzaki H; Adachi S; Tsubura A
Anticancer Res; 2000; 20(1A):203-12. PubMed ID: 10769656
[TBL] [Abstract][Full Text] [Related]
30. Immediate effects of anticancer drugs on mitochondrial oxygen consumption.
Souid AK; Tacka KA; Galvan KA; Penefsky HS
Biochem Pharmacol; 2003 Sep; 66(6):977-87. PubMed ID: 12963484
[TBL] [Abstract][Full Text] [Related]
31. Modification of the antitumor activity of chemotherapeutic drugs by the hypoxic cytotoxic agent tirapazamine.
Dorie MJ; Brown JM
Cancer Chemother Pharmacol; 1997; 39(4):361-6. PubMed ID: 9025778
[TBL] [Abstract][Full Text] [Related]
32. Effects of four chemotherapeutic agents, bleomycin, etoposide, cisplatin, and cyclophosphamide, on DNA damage and telomeres in a mouse spermatogonial cell line.
Liu M; Hales BF; Robaire B
Biol Reprod; 2014 Apr; 90(4):72. PubMed ID: 24571982
[TBL] [Abstract][Full Text] [Related]
33. [Preheating decrease the sensitivity of K562 cell to chemotherapeutic drugs].
Wang F; Zhao F; Guo J
Wei Sheng Yan Jiu; 1999 Mar; 28(2):81-3. PubMed ID: 11939009
[TBL] [Abstract][Full Text] [Related]
34. Bendamustine hydrochloride activity against doxorubicin-resistant human breast carcinoma cell lines.
Strumberg D; Harstrick A; Doll K; Hoffmann B; Seeber S
Anticancer Drugs; 1996 Jun; 7(4):415-21. PubMed ID: 8826610
[TBL] [Abstract][Full Text] [Related]
35. Effect of Paclitaxel on Antitumor Activity of Cyclophosphamide: Study on Two Transplanted Tumors in Mice.
Kaledin VI; Nikolin VP; Popova NA; Pyshnaya IA; Bogdanova LA; Morozkova TS
Bull Exp Biol Med; 2015 Nov; 160(1):81-3. PubMed ID: 26597686
[TBL] [Abstract][Full Text] [Related]
36. Differential impact of diverse anticancer chemotherapeutics on the Cdc25A-degradation checkpoint pathway.
Agner J; Falck J; Lukas J; Bartek J
Exp Cell Res; 2005 Jan; 302(2):162-9. PubMed ID: 15561098
[TBL] [Abstract][Full Text] [Related]
37. Neurophysiological study of peripheral neuropathy after high-dose Paclitaxel: lack of neuroprotective effect of amifostine.
Openshaw H; Beamon K; Synold TW; Longmate J; Slatkin NE; Doroshow JH; Forman S; Margolin K; Morgan R; Shibata S; Somlo G
Clin Cancer Res; 2004 Jan; 10(2):461-7. PubMed ID: 14760066
[TBL] [Abstract][Full Text] [Related]
38. Treatment with paclitaxel alone rather than combination with paclitaxel and cisplatin may be selective for cisplatin-resistant ovarian carcinoma.
Yamamoto K; Kikuchi Y; Kudoh K; Hirata J; Kita T; Nagata I
Jpn J Clin Oncol; 2000 Oct; 30(10):446-9. PubMed ID: 11185891
[TBL] [Abstract][Full Text] [Related]
39. Phase I clinical study of a static magnetic field combined with anti-neoplastic chemotherapy in the treatment of human malignancy: initial safety and toxicity data.
Salvatore JR; Harrington J; Kummet T
Bioelectromagnetics; 2003 Oct; 24(7):524-7. PubMed ID: 12955758
[TBL] [Abstract][Full Text] [Related]
40. Sequential adjuvant therapy with doxorubicin/paclitaxel/cyclophosphamide for resectable breast cancer involving four or more axillary nodes.
Hudis CA; Seidman AD; Baselga J; Raptis G; Lebwohl D; Gilewski T; Currie V; Moynahan ME; Sklarin N; Fennelly D
Semin Oncol; 1995 Dec; 22(6 Suppl 15):18-23. PubMed ID: 8643965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
